62 related articles for article (PubMed ID: 27602070)
1. High-dose-rate intraluminal brachytherapy for paraneoplastic autoimmune multiorgan syndrome.
Lee SY; Kim JH; Cho DH
Exp Ther Med; 2016 Sep; 12(3):1435-1439. PubMed ID: 27602070
[TBL] [Abstract][Full Text] [Related]
2. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus.
Nguyen VT; Ndoye A; Bassler KD; Shultz LD; Shields MC; Ruben BS; Webber RJ; Pittelkow MR; Lynch PJ; Grando SA
Arch Dermatol; 2001 Feb; 137(2):193-206. PubMed ID: 11176692
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic Pemphigus/Paraneoplastic Autoimmune Multiorgan Syndrome: Part II. Diagnosis and Management.
Huang S; Anderson HJ; Lee JB
J Am Acad Dermatol; 2023 Sep; ():. PubMed ID: 37714216
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus.
Amber KT; Valdebran M; Grando SA
Autoimmun Rev; 2018 Oct; 17(10):1002-1010. PubMed ID: 30103046
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic Autoimmune Multiorgan Syndrome: A Retrospective Study from a Tertiary Care Center in South India.
Sathishkumar D; Agrawal P; Baitule AM; Thomas M; Eapen A; Kumar S; George R
Indian Dermatol Online J; 2021; 12(4):572-576. PubMed ID: 34430462
[TBL] [Abstract][Full Text] [Related]
6. [Bronchiolitis obliterans associated with paraneoplastic pemphigus: a paraneoplastic autoimmune multiorgan syndrome].
Iranzo P; Xaubet A; Carrera C; Mascaró JM; Campo E; Herrero C
Arch Bronconeumol; 2004 May; 40(5):240-3. PubMed ID: 15117625
[TBL] [Abstract][Full Text] [Related]
7. RTOG, CTCAE and WHO criteria for acute radiation dermatitis correlate with cutaneous blood flow measurements.
Huang CJ; Hou MF; Luo KH; Wei SY; Huang MY; Su SJ; Kuo HY; Yuan SS; Chen GS; Hu SC; Chuang HY
Breast; 2015 Jun; 24(3):230-6. PubMed ID: 25777626
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome.
Sehgal VN; Srivastava G
Int J Dermatol; 2009 Feb; 48(2):162-9. PubMed ID: 19200194
[TBL] [Abstract][Full Text] [Related]
9. Treatment of upper gum carcinoma with high-dose-rate customized-mold brachytherapy.
Garrán C; Montesdeoca N; Martínez-Monge R
Brachytherapy; 2008; 7(3):267-9. PubMed ID: 18635026
[TBL] [Abstract][Full Text] [Related]
10. Outcome and late complications of radiotherapy in patients with unicentric Castleman disease.
Neuhof D; Debus J
Acta Oncol; 2006; 45(8):1126-31. PubMed ID: 17118850
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis.
Billet SE; Grando SA; Pittelkow MR
Autoimmunity; 2006 Nov; 39(7):617-30. PubMed ID: 17101506
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic pemphigus: a brief update.
Wade MS; Black MM
Australas J Dermatol; 2005 Feb; 46(1):1-8; quiz 9-10. PubMed ID: 15670168
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) in a child: case report and review of the literature.
Lane JE; Woody C; Davis LS; Guill MF; Jerath RS
Pediatrics; 2004 Oct; 114(4):e513-6. PubMed ID: 15466078
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]